M A6
Pill imprint M A6 has been identified as Alendronate sodium 5 mg.
Alendronate is used in the treatment of osteoporosis; prevention of osteoporosis; paget's disease; aseptic necrosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy.
Alendronate 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Alendronate sodium Images
- Imprint:
-
M
A6 - Strength:
- 5 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
crospovidone
magnesium stearate
mannitol
microcrystalline cellulose
sodium lauryl sulfate
- Drug Class:
- Bisphosphonates
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-3566
More Alendronate Sodium resources
- Alendronate (Wolters Kluwer)
- Alendronate Solution (Wolters Kluwer)
- alendronate (Cerner Multum)
- alendronate (Micromedex) - Includes Dosage Information
- Alendronate Sodium (AHFS DI)
- Alendronate (FDA)
- Alendronate Sodium (Wolters Kluwer)


